Bristol-Myers Squibb enters into agreement that provides an exclusive option to acquire F-star Alpha Ltd. and its novel HER2-targeted therapy
- Details
- Category: Bristol-Myers Squibb

AstraZeneca strengthens partnership with the University of Cambridge
- Details
- Category: AstraZeneca

Roche delivers solid sales growth for the first nine months of 2014
- Details
- Category: Roche

Novo Nordisk second best science employer in the world
- Details
- Category: Novo Nordisk

Bayer supports World Thrombosis Day as founding global partner
- Details
- Category: Bayer

Positive results from Phase IIb benralizumab study in severe asthma
- Details
- Category: AstraZeneca

New data on the global economic impact and burden of preventable blindness and vision impairment
- Details
- Category: Novartis

More Pharma News ...
- GSK commits further funding to advance bioelectronics research with creation of $5 million Innovation Challenge Fund
- Novartis announces clinical collaboration to evaluate Bristol-Myers Squibb's novel immunotherapy in combination treatments for NSCLC
- Bayer closes acquisition of consumer care business of Merck & Co., Inc., United States, for USD 14.2 billion
- Pfizer and Kyowa Hakko Kirin to collaborate on immuno-oncology combination study
- Novo Nordisk establishes new obesity research unit in Seattle
- MedImmune and Cancer Research UK establish joint CRUK-MEDI Alliance Laboratory
- Boehringer Ingelheim and CureVac announce collaboration to develop next generation lung cancer immunotherapy